Market capitalization | $0.00 |
Enterprise Value | $5.92m |
P/E (TTM) P/E ratio | 0.00 |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.15 |
P/S ratio (TTM) P/S ratio | 0.00 |
P/B ratio (TTM) P/B ratio | 0.00 |
Revenue (TTM) Revenue | $39.11m |
EBIT (operating result TTM) EBIT | $-46.62m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
1 Analyst has issued a forecast Neptune Technologies & Bioressources Inc.:
1 Analyst has issued a forecast Neptune Technologies & Bioressources Inc.:
Dec '23 |
+/-
%
|
||
Revenue | 39 39 |
-
|
|
Gross Profit | -0.76 -0.76 |
-
|
|
EBITDA | -45 -45 |
-
|
EBIT (Operating Income) EBIT | -47 -47 |
50%
50%
|
Net Profit | -54 -54 |
-
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Neptune Wellness Solutions, Inc. engages in the extraction, purification, and formulation of cannabis products, and provides customized turnkey solutions, and specialty ingredients for the nutrition industry. It focuses on the development of value added and differentiated products for the Canadian and global cannabis markets. Its activities include the development and commercialization of turnkey nutrition solutions and patented ingredients such as MaxSimil, and of a variety of marine and seed oils. The firm also active in five main areas such as Legal Cannabis Products, Turnkey Nutrition Solutions, Ingredients, Pet Supplements, and Consumer Brands. The company was founded by Henri Harland on October 9, 1998 and is headquartered in Laval, Canada.
Head office | Canada |
CEO | Michael Geus |
Founded | 1998 |
Website | www.neptunewellness.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.